Cognitive Remediation Therapy for Depression

(CogRemVet Trial)

No longer recruiting at 1 trial location
AA
EA
Overseen ByErin A Hazlett-Oakes, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: VA Office of Research and Development
Stay on Your Current MedsYou can continue your current medications while participating
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new therapy called Cognitive Remediation Therapy to assist Veterans with depression who have attempted suicide. The focus is on enhancing cognitive skills and problem-solving to manage real-life stress that may trigger suicidal thoughts. Delivered online over 10 weeks, the therapy aims to improve mental health and quality of life. Veterans with depression, a suicide attempt in the past year, and who are currently in therapy might be suitable candidates. As an unphased trial, this study provides Veterans with a unique opportunity to access innovative therapy that could enhance their mental well-being.

Will I have to stop taking my current medications?

The trial protocol does not specify whether you need to stop taking your current medications. However, since participants must be in psychotherapy treatment as usual, it seems likely that you can continue your current treatments.

What prior data suggests that this cognitive remediation therapy is safe for Veterans with depression?

In earlier studies, the Neuropsychological Educational Approach to Cognitive Remediation (NEAR) has been used with individuals who have mental health conditions, yielding encouraging results. NEAR aims to improve thinking skills, which are essential for learning and problem-solving.

Research has shown that NEAR is generally well-tolerated, with most participants experiencing no serious side effects. Participants in studies completed sessions without major issues, indicating that the treatment is safe to try. However, as this is a newer approach for treating depression linked with suicidal risk, further research is necessary to fully understand all possible effects.

Prospective participants should discuss any concerns with a healthcare provider, who can offer advice based on personal health needs.12345

Why are researchers excited about this trial?

Researchers are excited about the Cognitive Remediation plus Bridging technique for depression because it focuses on improving cognitive functions, like memory and attention, which are often impaired in people with depression. Unlike traditional talk therapy or medication that primarily targets mood symptoms, this approach uses structured cognitive exercises to directly enhance brain function. This method is particularly promising for veterans at high risk for suicide, as it aims to provide them with tools for better cognitive control and decision-making, potentially leading to improved mental health outcomes.

What evidence suggests that this cognitive remediation therapy is effective for depression?

Research has shown that the Neuropsychological Educational Approach to Cognitive Remediation (NEAR) can enhance thinking skills and alleviate symptoms of depression. Studies have found that NEAR improves mental functioning and increases well-being in individuals with depression. This treatment targets brain abilities such as attention, memory, and problem-solving, which depression often affects. Although further research is necessary, early results suggest this approach may assist those at high risk for suicide by enhancing their ability to manage stress and daily challenges. Participants in this trial will receive the Cognitive Remediation plus Bridging intervention to evaluate its feasibility and effectiveness.23567

Who Is on the Research Team?

EA

Erin A Hazlett-Oakes, PhD

Principal Investigator

James J. Peters Veterans Affairs Medical Center

Are You a Good Fit for This Trial?

This trial is for U.S. Veterans aged 18-60 with major depressive disorder and a history of suicide attempts within the past year. They must have current suicidal thoughts without immediate plans to act on them, be in ongoing psychotherapy, and score high on rumination measures. Women are encouraged to participate, aiming for at least 30% female participants.

Inclusion Criteria

You are a military veteran from the United States.
You have a high score on a test that measures how much you think about the same things over and over.
You must be between 18 and 60 years old.
See 4 more

Exclusion Criteria

You have had a head injury in the past.
You have serious difficulty with thinking and understanding things.
You currently have a problem with using drugs or alcohol.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive a 10-week (20 session) cognitive remediation intervention via telehealth

10 weeks
20 sessions (virtual)

Post-treatment Assessment

Post-treatment assessments of neurocognitive, clinical, social, and real-world functioning are conducted

1 week

Follow-up

Participants are monitored for safety and effectiveness after treatment

10 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed Cognitive Remediation plus Bridging)
Trial Overview The study tests a new cognitive therapy called NEAR (Cognitive Remediation plus Bridging) delivered via telehealth over 10 weeks with 20 sessions. It's designed to help veterans improve decision-making and manage stressors that could lead to suicidal thoughts by practicing problem-solving strategies.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Cognitive Remediation+Bridging InterventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

VA Office of Research and Development

Lead Sponsor

Trials
1,691
Recruited
3,759,000+

Citations

Practice Principles and Outcome StudiesNEAR is an evidence based approach to cognitive remediation which was specifically developed for use with psychiatric patients.
Augmenting neurocognitive remediation therapy to ...This study will examine the effectiveness of augmenting oNCRT to PCT in a pragmatic national multicentre superiority randomised controlled trial.
3.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/40754805/
Effectiveness of cognitive remediation in subjects with ...Outcomes were measured with validated instruments by blind assessors and included cognitive performance, depressive symptoms, and psychosocial ...
Cognitive remediation as a treatment for major depressionHowever, data on the neuropsychological function and neurobiology of MDD suggest that this is an approach that deserves further attention and research.
The FOCUS trial: cognitive remediation plus standard ...The FOCUS trial results will provide evidence on the effect of targeted and comprehensive cognitive rehabilitation on cognition, daily living, ...
A Novel Cognitive Remediation Intervention Targeting ...The Neuropsychological Educational Approach to Cognitive Remediation (NEAR, termed CR pus bridging session) intervention involves 20 90-minute sessions (2x/week ...
Brain-Cognition Associations in Older Patients With ...Almost half of older patients with major depressive disorder (MDD) present with cognitive impairment, and one-third meet diagnostic criteria ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security